Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Joerg C. Prinz"'
Autor:
Markus V. Heppt, Jerome Srour, Adel Alsenaid, Joerg C. Prinz, Ben Min-Woo Illigens, Mohammad Ezmerli
Publikováno v:
Journal of Dermatological Treatment. 33:473-482
Scalp psoriasis is common in psoriasis patients, difficult to treat and manifests a significant burden on quality of life.Efficacy assessment of biologics and small molecules in scalp psoriasis with reported safety and quality of life.Biological ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799d4354c9461024ae821cdf7a0346d6
https://doi.org/10.1080/09546634.2020.1770167
https://doi.org/10.1080/09546634.2020.1770167
Autor:
Song-Min Kim, Latika Bhonsle, Petra Besgen, Jens Nickel, Anna Backes, Kathrin Held, Sigrid Vollmer, Klaus Dornmair, Joerg C Prinz
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e37338 (2012)
Analysis of the paired i.e. matching TCR α- and β-chain rearrangements of single human T cells is required for a precise investigation of clonal diversity, tissue distribution and specificity of protective and pathologic T-cell mediated immune resp
Externí odkaz:
https://doaj.org/article/141f68b0bee54dbc82de11d50c00bd38
Publikováno v:
Journal of Photochemistry and Photobiology B: Biology. 161:396-401
Psoriasis is a common, chronic immune-mediated inflammatory disease. The inflammatory process in psoriasis has systemic effects and may influence the development of psoriatic comorbidities. The systemic action of phototherapy in patients with psorias
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c98e06cff4079ce38d17d320ee09487b
https://doi.org/10.1016/j.jphotobiol.2016.05.023
https://doi.org/10.1016/j.jphotobiol.2016.05.023
Publikováno v:
Therapeutic Advances in Chronic Disease. 7:18-33
The first oral treatment for relapsing multiple sclerosis, the nonselective sphingosine-1-phosphate receptor (S1PR) modulator fingolimod, led to identification of a pivotal role of sphingosine-1-phosphate and one of its five known receptors, S1P1R, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa83f04e5e1c08c9e6a6dcf3c7a1eb13
https://doi.org/10.1177/2040622315617354
https://doi.org/10.1177/2040622315617354
Publikováno v:
Expert Opinion on Drug Safety. 11:911-921
Etanercept (ETN) is a tumor necrosis factor alpha (TNF-α) antagonist used for the treatment of chronic inflammatory disorders. Injection site reactions (ISRs) are reported to be the most common adverse event of ETN therapy. While their mechanisms ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c9172877e3535fde9eca01308bec701
https://doi.org/10.1517/14740338.2012.727796
https://doi.org/10.1517/14740338.2012.727796
Autor:
Joerg C. Prinz
Publikováno v:
Nature Reviews Rheumatology. 7:429-434
Tumor necrosis factor (TNF) antagonists are effective treatments for immune-mediated inflammatory disorders. The most dreaded adverse events associated with these agents are severe infections. Occasionally, patients develop autoimmune-like syndromes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2996ab2e3ffe14f8436419f9fac72a2a
https://doi.org/10.1038/nrrheum.2011.35
https://doi.org/10.1038/nrrheum.2011.35
Autor:
Esteban Daudén, Knud Kragballe, Jo Lambert, Andreas Katsambas, Lluís Puig, Wolfram Sterry, Wolf-Henning Boehncke, Peter H. Hoeger, Mona Ståhle, Nilgün Atakan, Peter van de Kerkhoff, Alberto Giannetti, Marieke M B Seyger, Joerg C. Prinz, Robert Strohal, Jean-Paul Ortonne, Pascal Joly, Sergio Chimenti
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 8:812-819
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b90335e701ff98e08851236fd98956a3
https://doi.org/10.1111/j.1610-0387.2010.07507_supp.x
https://doi.org/10.1111/j.1610-0387.2010.07507_supp.x
Autor:
Joerg C. Prinz, Zita Battyáni, Peter Weisenseel, Thomas Ruzicka, László Pótó, Zsuzsanna Kutasi
Publikováno v:
Journal of the American Academy of Dermatology. 60:248-255
Background Morphea is an inflammatory autoimmune skin sclerosis of unknown etiology. A causative role of Borrelia burgdorferi infection has been controversially discussed, but no conclusive solution has yet been achieved. Objective Intrigued by 3 you
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4337b3dbc3fe80b2b66b2755cfba3aa2
https://doi.org/10.1016/j.jaad.2008.09.023
https://doi.org/10.1016/j.jaad.2008.09.023
Autor:
Elena Campione, Evelin Jasmine Paternò, Annamaria Mazzotta, Sergio Chimenti, Laura Diluvio, Joerg C. Prinz
Publikováno v:
Acta Dermato Venereologica. 89:288-291
Patients who respond only partially to etanercept may require additional treatments that act synergistically to improve their therapeutic response while at the same time reducing the dose required and the risk of side-effects. The aim of this study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a3c8d14d34baeb8b0cbff9e9a6b2e83
https://doi.org/10.2340/00015555-0585
https://doi.org/10.2340/00015555-0585
Autor:
Joerg C. Prinz
Publikováno v:
The Journal of rheumatology. Supplement. 93
Translational research is a coordinated process that converts scientific knowledge about diseases from basic research into the development of therapeutic or diagnostic procedures in order to improve public health. Recent insights into the pathogenesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f75e89e2e4d458af33c72a1675273a5
https://pubmed.ncbi.nlm.nih.gov/26523048
https://pubmed.ncbi.nlm.nih.gov/26523048